Publication details

Stanovisko ČSAT ke Konsenzu Evropské společnosti pro aterosklerózu: Lipoprotein(a) při aterosklerotických kardiovaskulárních onemocněních a aortální stenóze

Investor logo
Title in English Statement CSAT on Consensus statement of the European Atherosclerosis Society: Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis
Authors

VRABLÍK Michal BLÁHA Vladimír CÍFKOVÁ Renata FREIBERGER Tomáš KARÁSEK David KRAML Pavel PIŤHA Jan ROSOLOVÁ Hana SOŠKA Vladimír ŠTULC Tomáš ZLATOHLÁVEK Lukáš MAŠKOVÁ Jana

Year of publication 2023
MU Faculty or unit

Faculty of Medicine

web https://athero.cz/2023/06/28/stanovisko-csat-ke-konsenzu-evropske-spolecnosti-pro-aterosklerozu-lipoproteina-pri-aterosklerotickych-kardiovaskularnich-onemocnenich-a-aortalni-stenoze/
Attached files
Description In October 2022, an expert consensus on lipoprotein(a) was published in the European Heart Journal [Kronenberg et al. Lipoprotein( a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement. Eur Heart J 2022; 43(39): 3925-3946]. The Committee of the Czech Society for Atherosclerosis (CSAT) developed the following summary of the most important information for the Czech professional community. However, this summary in the Czech language does not replace the original published consensus, and those interested in the detailed text are therefore recommended to read the original full text. The numbering of references in square brackets in this Opinion corresponds to the original publication.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info